首页> 美国卫生研究院文献>Case Reports in Nephrology and Dialysis >Successful Treatment of Adult IgA Nephropathy with Nephrotic-Level Proteinuria by Combination Therapy Including Long-Term Coadministration of Mizoribine
【2h】

Successful Treatment of Adult IgA Nephropathy with Nephrotic-Level Proteinuria by Combination Therapy Including Long-Term Coadministration of Mizoribine

机译:长期联合服用米佐立滨的联合疗法成功治疗了具有肾病水平蛋白尿的成人IgA肾病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A 41-year-old male patient was admitted to our hospital due to massive proteinuria and hematuria. His 24-hour urinary protein excretion and the number of urinary erythrocytes were 3.91 g/day and 50–99/high-power field, respectively. A renal biopsy showed a severe pathological pattern of immunoglobulin A nephropathy (IgAN) that involved marked endocapillary proliferation and segmental sclerosis (Oxford-MEST score: M0, E1, S1, T0). Because he had nephrotic-level proteinuria with severe pathological findings, which are tonsillectomy and corticosteroid pulse therapy-resistant characteristics, he received mizoribine for a long period as part of the combination therapy using corticosteroid, tonsillectomy, dipyridamole, warfarin and renin-angiotensin-aldosterone system blockers. Twelve months after the beginning of treatment, his urinary findings were normal. In this report, we describe the pathological findings and successful treatment course, and discuss the potential effects of long-term coadministration of mizoribine for adult IgAN treatment.
机译:一名41岁的男性患者因大量蛋白尿和血尿入院。他的24小时尿蛋白排泄量和尿红细胞数量分别为3.91 g / day和50–99 / high-power域。肾活检显示严重的免疫球蛋白A肾病(IgAN)病理模式,涉及明显的毛细血管内膜增生和节段性硬化(Oxford-MEST评分:M0,E1,S1,T0)。由于他患有肾病性蛋白尿并伴有严重的病理学发现,即扁桃体切除术和皮质类固醇脉冲治疗耐药性,因此他长期接受咪唑立滨作为联合治疗的一部分,使用皮质类固醇,扁桃体切除术,双嘧达莫,华法林和肾素-血管紧张素-醛固酮系统阻止程序。开始治疗后十二个月,他的尿液检查结果正常。在本报告中,我们描述了病理结果和成功的治疗过程,并讨论了长期联合服用咪唑立滨对成人IgAN治疗的潜在影响。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号